73Information to be given before prescribing substance

#### 73 Information to be given before prescribing substance 73 Information to be given before prescribing substance > > (1) This section applies if— > > > > > (a) a patient has made an administration decision, and > > > > > (b) the Board has issued a voluntary assisted dying substance authority in relation to the patient. > > > (2) The patient’s coordinating practitioner must, if the patient has made a self-administration decision, before prescribing a voluntary assisted dying substance for the patient, inform the patient, in writing, of the following— > > > > > (a) the Schedule 4 poison or Schedule 8 poison, or combination of poisons, constituting the substance, > > > > > (b) that the patient is not under an obligation to obtain the substance, > > > > > (c) that the patient is not under an obligation to self-administer the substance, > > > > > (d) how to dispense the substance, > > > > > (e) that the substance must be stored— > > > > > > > (i) in a locked box that complies with the requirements stated in section 79, and > > > > > > > (ii) otherwise in accordance with the information provided by the authorised supplier who supplies the substance, > > > > > (f) how to prepare and self-administer the substance, > > > > > (g) the method by which the substance will be self-administered, > > > > > (h) the expected effects of self-administration of the substance, > > > > > (i) the period within which the patient is likely to die after self-administration of the substance, > > > > > (j) the potential risks of self-administration of the substance, > > > > > (k) that, if the patient decides not to self administer the substance, the patient’s contact person must give the substance to an authorised disposer for disposal, > > > > > (l) that, if the patient dies, the patient’s contact person must give any unused or remaining substance to an authorised disposer for disposal. > > > (3) The coordinating practitioner for a patient who has made a practitioner administration decision must, before prescribing a voluntary assisted dying substance for the patient, inform the patient, in writing, of the following— > > > > > (a) the Schedule 4 poison or Schedule 8 poison, or combination of poisons, constituting the substance, > > > > > (b) that the patient is not under an obligation to have the substance administered, > > > > > (c) how the substance will be dispensed, > > > > > (d) the method by which the substance will be administered, > > > > > (e) the expected effects of administration of the substance, > > > > > (f) the period within which the patient is likely to die after administration of the substance, > > > > > (g) the potential risks of administration of the substance, > > > > > (h) that, if the practitioner administration decision is made after the revocation of a self-administration decision, the patient’s contact person must give any prescribed substance received by the patient, the contact person or an agent of the patient, to an authorised disposer for disposal.